Conferences
SUO 2013 - Session Highlights: Neoadjuvant androgen-targeted therapy for high-risk prostate cancer
December 6, 2013
SUO 2013 - Session Highlights: Aberrations in the androgen receptor
December 6, 2013
SUO 2013 - Session Highlights: Practical issues in management of bladder cancer - Case presentation
December 6, 2013
SUO 2013 - Session Highlights: Translocator protein (TSPO): Potential as a novel biomarker in renal cell carcinoma
December 6, 2013
SUO 2013 - Session Highlights: Micro-RNA and gene expression subtypes of high-grade, muscle invasive urothelial carcinoma
December 6, 2013
SUO 2013 - Session Highlights: How does FDA approval of a device differ from the approval of a drug?
December 6, 2013
SUO 2013 - Session Highlights: Mechanism of castration resistance
December 6, 2013
SUO 2013 - Session Highlights: Biomarkers: What is the evidence they are useful in selecting/monitoring the active surveillance (AS) patient?
December 6, 2013
SUO 2013 - Session Highlights: Genomic markers in bladder cancer
December 6, 2013
SUO 2013 - Session Highlights: Patient selection and monitoring
December 6, 2013
SUO 2013 - Session Highlights: Translational science in urothelial cancers: TCGA update
December 5, 2013